Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Total Debt (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Total Debt for 16 consecutive years, with $28.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Debt rose 31.18% to $28.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $28.7 million, a 31.18% increase, with the full-year FY2024 number at $34.2 million, up 56.77% from a year prior.
  • Total Debt was $28.7 million for Q3 2025 at Xtant Medical Holdings, down from $34.3 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $34.3 million in Q2 2025 to a low of $12.0 million in Q3 2022.
  • A 5-year average of $21.3 million and a median of $17.1 million in 2023 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: plummeted 80.95% in 2021, then surged 96.79% in 2024.
  • Xtant Medical Holdings' Total Debt stood at $15.4 million in 2021, then fell by 21.98% to $12.0 million in 2022, then skyrocketed by 81.27% to $21.8 million in 2023, then surged by 56.77% to $34.2 million in 2024, then fell by 15.94% to $28.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Total Debt are $28.7 million (Q3 2025), $34.3 million (Q2 2025), and $33.4 million (Q1 2025).